Early and accurate detection of cancer can significantly improve the prognosis and survival rates of patients. Diagnostic imaging trials help in assessing the efficacy of new imaging technologies like MRI, CT scans, PET scans, and ultrasound. These trials also explore novel imaging agents that can highlight cancerous tissues more effectively than traditional methods.
